MAFM
TECH icon

Mid Atlantic Financial Management’s Bio-Techne TECH Stock Holding History

Mid Atlantic Financial Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,056
Closed -$794K – 970
2021
Q2 		$794K Hold
7,056
– – 0.05% 318
2021
Q1 		$674K Buy
+7,056
New +$644K 0.05% 357

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Mid Atlantic Financial Management's TECH Position: Q3 2021 in Review

Mid Atlantic Financial Management sold out of Bio-Techne (TECH) in Q3 2021, closing a stake of 7,056 shares — an estimated $794K sold.

Mid Atlantic Financial Management first reported a position in TECH in Q1 2021 and held it in 2 quarters. The position peaked at $794K in Q2 2021. 566 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

  • Mid Atlantic Financial Management reported no remaining Bio-Techne position as of Q3 2021 after selling out during the quarter.
  • Mid Atlantic Financial Management sold 7,056 Bio-Techne shares in Q3 2021, an estimated $794K.
  • Mid Atlantic Financial Management first reported a position in Bio-Techne in Q1 2021 and held it in 2 quarters.
  • Mid Atlantic Financial Management's Bio-Techne position peaked at $794K in Q2 2021.
  • 566 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.